A Novel Interaction between Thyroid Hormones and 1,25(OH)2D3 in Osteoclast Formation
- 8 March 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 291 (4), 987-994
- https://doi.org/10.1006/bbrc.2002.6561
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand FamiliesEndocrine Reviews, 1999
- Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligandProceedings of the National Academy of Sciences, 1999
- A New Member of Tumor Necrosis Factor Ligand Family, ODF/OPGL/TRANCE/RANKL, Regulates Osteoclast Differentiation and FunctionBiochemical and Biophysical Research Communications, 1999
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone DensityCell, 1997
- Thyroid hormones and boneJournal of Endocrinology, 1993
- Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitroBiochemical and Biophysical Research Communications, 1991
- Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells.The Journal of Experimental Medicine, 1991
- SPINAL BONE MINERAL CONTENT IN MYXOEDEMA AND THYROTOXICOSIS. EFFECTS OF THYROID HORMONE(S) AND ANTITHYROID TREATMENTClinical Endocrinology, 1983
- A Tetracycline‐Based Histomorphometric Evaluation of Bone Resorption and Bone Turnover in Hyperthyroidism and HyperparathyroidismActa Medica Scandinavica, 1978